Results for "Metformin TAME Trial" in Diabetes

20 articles

Metformin Shows Promise for Better Surgical Recovery in Older Adults
Metabolic Health

Metformin Shows Promise for Better Surgical Recovery in Older Adults

Clinical trial tested whether metformin could improve surgical outcomes and reduce hospital stays in non-diabetic older patients.

Clinical Trial
Mar 28, 2026 1
Metformin Shows Promise for Preventing Frailty in Older Adults
Metabolic Health

Metformin Shows Promise for Preventing Frailty in Older Adults

Major trial tests whether diabetes drug metformin can prevent frailty syndrome that affects millions of aging adults.

Clinical Trial
Mar 28, 2026 1
Metformin Shows Promise for Protecting Memory in Early Cognitive Decline
Metabolic Health

Metformin Shows Promise for Protecting Memory in Early Cognitive Decline

Columbia University tested whether the diabetes drug metformin could slow memory loss in people with mild cognitive impairment.

Clinical Trial
Mar 29, 2026 1
Metformin Shows Promise for Healthy Aging in Non-Diabetic Adults
Metabolic Health

Metformin Shows Promise for Healthy Aging in Non-Diabetic Adults

Wake Forest study explores whether the diabetes drug metformin can trigger cellular changes linked to longevity in healthy people.

Clinical Trial
Mar 28, 2026 1
Metformin Plus Strength Training Shows Promise for Muscle Building in Seniors
Metabolic Health

Metformin Plus Strength Training Shows Promise for Muscle Building in Seniors

Clinical trial tested whether metformin could enhance resistance training benefits for muscle mass and strength in older adults.

Clinical Trial
Mar 28, 2026 1
Metformin Shows Promise for Improving Blood Vessel Health in Metabolic Syndrome
Metabolic Health

Metformin Shows Promise for Improving Blood Vessel Health in Metabolic Syndrome

Four-year study examined whether metformin could protect blood vessels in people with metabolic syndrome beyond its diabetes benefits.

Clinical Trial
Mar 28, 2026 1
Metformin Study Explores Insulin-Testosterone Link in Postmenopausal Women
Metabolic Health

Metformin Study Explores Insulin-Testosterone Link in Postmenopausal Women

University of Pennsylvania researchers investigated how insulin resistance and testosterone interact in women after menopause.

Clinical Trial
Mar 28, 2026 1
Metformin Shows Promise for Boosting Vaccine Response in Older Adults
Metabolic Health

Metformin Shows Promise for Boosting Vaccine Response in Older Adults

Small trial tested whether the diabetes drug metformin could enhance immune response to pneumonia vaccine in aging adults.

Clinical Trial
Mar 28, 2026 1
Metformin May Help or Harm Aging Based on Your Insulin Sensitivity
Metabolic Health

Metformin May Help or Harm Aging Based on Your Insulin Sensitivity

New study reveals metformin's anti-aging effects depend entirely on whether you're insulin resistant or sensitive.

Clinical Trial
Mar 28, 2026 1
CT-868 Dual Agonist Targets Blood Sugar and Obesity in Phase 2 Diabetes Trial
Metabolic Health

CT-868 Dual Agonist Targets Blood Sugar and Obesity in Phase 2 Diabetes Trial

Carmot Therapeutics tests CT-868, a novel dual incretin receptor agonist, for HbA1c reduction in overweight and obese adults with poorly controlled T2DM.

Clinical Trial
Jun 16, 2026 0
Metformin May Boost Flu Vaccine Response in Older Adults
Metabolic Health

Metformin May Boost Flu Vaccine Response in Older Adults

Small trial tests whether diabetes drug metformin can enhance immune response to flu vaccination in aging adults.

Clinical Trial
Mar 29, 2026 2
Diet, Exercise and Metformin Combination Shows Promise for Reversing Frailty in Seniors
Metabolic Health

Diet, Exercise and Metformin Combination Shows Promise for Reversing Frailty in Seniors

VA study tests whether combining lifestyle changes with metformin can reverse muscle loss and frailty in obese older adults.

Clinical Trial
Mar 28, 2026 1
Diabetes Drug Pioglitazone Shows Promise for Reversing Fatty Liver Disease
Metabolic Health

Diabetes Drug Pioglitazone Shows Promise for Reversing Fatty Liver Disease

176-person trial tested whether pioglitazone could improve liver health by targeting insulin resistance in patients with fatty liver disease.

Clinical Trial
Mar 29, 2026 2
MASH Treatment Revolution: Semaglutide, Tirzepatide Lead a New Drug Era
Metabolic Health

MASH Treatment Revolution: Semaglutide, Tirzepatide Lead a New Drug Era

A landmark JCI review maps the expanding pharmacological arsenal for MASH, from GLP-1 agonists to triple receptor therapies and precision medicine.

Research Paper
May 30, 2026 0
Small-Sided Football Games Tested as Hybrid Exercise Therapy for Type 2 Diabetes
Metabolic Health

Small-Sided Football Games Tested as Hybrid Exercise Therapy for Type 2 Diabetes

A completed RCT tests whether small-sided football sessions 3x/week improve glucose control and metabolic health in T2DM patients on GLP-1 and SGLT2 drugs.

Clinical Trial
Jun 14, 2026 0
GLP-1 Drugs and Metformin Trim BMI in Obese Youth but Long-Term Safety Remains Unknown
Metabolic Health

GLP-1 Drugs and Metformin Trim BMI in Obese Youth but Long-Term Safety Remains Unknown

A Cochrane review of 37 RCTs finds obesity drugs modestly reduce weight in adolescents, but evidence quality is low and long-term data are absent.

Review
May 14, 2026 0
Triple Therapy Targets Diabetes and Muscle Loss in Elderly Adults
Metabolic Health

Triple Therapy Targets Diabetes and Muscle Loss in Elderly Adults

Mediterranean diet, resistance training, and diabetes medication combined to combat sarcopenia and improve metabolic health in older adults.

Clinical Trial
Mar 28, 2026 1
Landmark Study Shows Lifestyle Changes Cut Diabetes Risk by 58% in High-Risk Adults
Metabolic Health

Landmark Study Shows Lifestyle Changes Cut Diabetes Risk by 58% in High-Risk Adults

Major prevention trial proves diet and exercise dramatically reduce diabetes onset compared to medication alone.

Clinical Trial
Mar 29, 2026 7
Tirzepatide Cuts Cardiovascular Risk More Than Semaglutide in Sleep Apnea Patients
Metabolic Health

Tirzepatide Cuts Cardiovascular Risk More Than Semaglutide in Sleep Apnea Patients

A real-world study of 15,000+ patients finds tirzepatide outperforms both semaglutide and liraglutide in preventing major cardiac events.

Research Paper
Jun 4, 2026 0
More Powerful GLP-1 Drugs Don't Mean More Side Effects, Major Analysis Finds
Metabolic Health

More Powerful GLP-1 Drugs Don't Mean More Side Effects, Major Analysis Finds

A systematic review of 38 trials finds tirzepatide cuts HbA1c nearly 3x more than lixisenatide with similar GI side effect rates.

Research Paper
Jun 4, 2026 0
Page 1 of 2Next